Solu-medrol Injection, Powder, For Solution
Product Images NDC 0009-0850

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Solu-medrol (NDC 0009-0850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Solu Medrol 01)

Chemical structure diagram of methylprednisolone sodium succinate, showing its steroid backbone with functional groups and sodium succinate moiety as part of the molecule structure.*

FDA Label Image

Figure (Solu Medrol 02)

An instructional diagram illustrating the connection between a vial's rubber stopper and a syringe needle, showing the needle piercing through the stopper for withdrawal of medication.*

FDA Label Image

Logo (Solu Medrol 03)

FDA Label Image

Principal Display Panel (500 mg Vial Label)

Solu-Medrol 500 mg injection powder for solution vial label showing methylprednisolone sodium succinate as active ingredient. It is a multi-dose vial for intramuscular or intravenous use distributed by Pharmacia & Upjohn Company LLC. The label includes storage instructions, reconstitution directions with 8 mL bacteriostatic water, and usage warnings. The label states this package does not contain diluent, which contains benzyl alcohol as preservative.*

FDA Label Image

Principal Display Panel (500 mg Vial Carton)

Packaging label for SOLU-MEDROL 500 mg per vial injection powder, methylprednisolone sodium succinate for injection, USP. The label indicates a multi-dose vial for intramuscular or intravenous use, distributed by Pharmacia & Upjohn Company LLC, a division of Pfizer Inc. Storage instructions, reconstitution directions with 8 mL bacteriostatic water with benzyl alcohol, and cautions on diluent absence are also visible.*

FDA Label Image

Principal Display Panel (1 gram Vial Label)

Solu-Medrol (methylprednisolone sodium succinate) injection label for 1 gram per vial. The multi-dose vial is for intramuscular or intravenous use only, distributed by Pharmacia & Upjohn Co. The label includes storage instructions, diluent requirements, and dosage preparation notes, highlighting that this package does not contain diluent and that benzyl alcohol is used as a preservative.*

FDA Label Image

Principal Display Panel (1 gram Vial Carton)

Packaging label for Solu-Medrol 1 gram vial, injection powder for solution containing methylprednisolone sodium succinate. It is a multi-dose vial for intramuscular or intravenous use only. Label includes storage instructions, dilution guidance using bacteriostatic water with benzyl alcohol, manufacturer Pfizer logo, and distributor information for Pharmacia & Upjohn Co, Division of Pfizer Inc.*

FDA Label Image

Principal Display Panel (2 gram Vial Label)

Solu-Medrol 2 grams per vial injection, powder for solution, methylprednisolone sodium succinate for intramuscular or intravenous use. Single-use vial label includes storage instructions, reconstitution details with bacteriostatic water for injection, and a caution about benzyl alcohol preservative. Distributed by Pharmacia & Upjohn Company LLC.*

FDA Label Image

Principal Display Panel (2 gram Vial Carton)

Packaging label for Solu-Medrol 2 grams per vial, a methylprednisolone sodium succinate injection powder for solution. It is for intramuscular or intravenous use only, supplied by Pharmacia & Upjohn Company LLC, a division of Pfizer Inc. The label includes storage instructions, dosage information, and notes the enclosed bacteriostatic water diluent with benzyl alcohol preservative.*

FDA Label Image

Principal Display Panel (40 mg Vial Label)

Solu-Medrol 40 mg per vial injection, powder for solution in a 1 mL Act-O-Vial. Contains methylprednisolone sodium succinate for intramuscular or intravenous use. Single-dose vial, preservative-free. Distributed by Pharmacia & Upjohn Company LLC, a division of Pfizer Inc., NY.*

FDA Label Image

Principal Display Panel (40 mg Vial Carton)

Packaging label for Solu-Medrol 40 mg per vial injection powder, methylprednisolone sodium succinate for injection USP. The label indicates single-dose vial usage, preservative-free formulation, and administration via intramuscular or intravenous route. The labeler is Pfizer Injectables, Pharmacia & Upjohn Company LLC, with storage instructions and barcode visible.*

FDA Label Image

Principal Display Panel (40 mg Vial Label)

Label for SOLU-MEDROL 40 mg/mL injection powder for solution, methylprednisolone sodium succinate for injection USP in a single-dose vial. The label indicates it is preservative-free, for intramuscular or intravenous use only, and includes dosage information. Distributed by Pharmacia & Upjohn Company LLC.*

FDA Label Image

Principal Display Panel (40 mg Vial Carton)

Packaging label for SOLU-MEDROL injection, powder for solution, containing methylprednisolone sodium succinate for injection, USP. The label indicates a strength of 40 mg per vial, single-dose vials, preservative-free in 25–1 mL Act-O-Vial Systems. It notes use for intramuscular or intravenous administration, distributed by Pharmacia & Upjohn Company LLC, with branding for novaplus.*

FDA Label Image

Principal Display Panel (125 mg Vial Label)

Label for Solu-Medrol injection powder for solution, methylprednisolone sodium succinate, 125 mg per 2 mL vial. The label indicates single-dose vial usage for intramuscular or intravenous administration, preservative-free, with instructions to protect from light and discard unused portions. Distributed by Pharmacia & Upjohn Co., a Pfizer division.*

FDA Label Image

Principal Display Panel (125 mg Vial Carton)

Packaging label for Solu-Medrol 125 mg per vial, an injection powder for solution containing methylprednisolone sodium succinate. The label indicates it is preservative-free and for intramuscular or intravenous use only. Distributed by Pharmacia & Upjohn Company LLC, a division of Pfizer. The label includes branding with Pfizer Injectables and instructions for use.*

FDA Label Image

Principal Display Panel (125 mg Vial Label)

Label for SOLU-MEDROL 125 mg injection powder for solution, methylprednisolone sodium succinate, supplied in a single-dose vial. The vial is preservative-free with a 2 mL Act-O-Vial system, intended for IM or IV use only. Distributed by Pharmacia & Upjohn Company LLC, the label includes instructions to protect from light and discard unused portions.*

FDA Label Image

Principal Display Panel (125 mg Vial Carton)

Packaging label for SOLU-MEDROL 125 mg per vial, methylprednisolone sodium succinate for injection, USP. This preservative-free injection is intended for intramuscular or intravenous use and supplied in single-dose vials. The label displays the product name prominently with dosage strength, the route of administration, and distributor information from Pharmacia & Upjohn Company LLC.*

FDA Label Image

Principal Display Panel (500 mg Vial Label)

Label for Solu-Medrol 500 mg injection powder for solution, methylprednisolone sodium succinate, USP. Single-dose vial, preservative-free, with instructions for intramuscular or intravenous use. Distributed by Pharmacia & Upjohn Company LLC, Pfizer. Includes storage, dilution, and usage information along with NDC 0009-0003-02.*

FDA Label Image

Principal Display Panel (500 mg Vial Carton)

Packaging label for Solu-Medrol 500 mg per vial injection powder, methylprednisolone sodium succinate, for intramuscular or intravenous use. Single-dose vial with 4 mL Act-O-Vial system. Preservative-free. Manufactured by Pharmacia & Upjohn Company LLC, a division of Pfizer Inc. Includes dosage and use instructions, storage conditions, and barcode.*

FDA Label Image

Principal Display Panel (1 gram Vial Label)

Label for Solu-Medrol injection powder, methylprednisolone sodium succinate, 1 gram per vial, single-dose vial. Directions specify intramuscular or intravenous use, storage at controlled room temperature, and use within 48 hours after mixing. Distributed by Pharmacia & Upjohn Company LLC, part of Pfizer Inc. Preservative-free and Rx only.*

FDA Label Image

Principal Display Panel (1 gram Vial Carton)

Packaging label for SOLU-MEDROL (methylprednisolone sodium succinate) injection powder for solution, 1 gram per vial. Single-dose vial, preservative-free, for intramuscular or intravenous use only. The label includes storage instructions, dosage and use information, Pfizer Injectables branding, and distributor details for Pharmacia & Upjohn Co.*

FDA Label Image

Principal Display Panel (2 grams Vial Label)

Label for SOLU-MEDROL injection, powder for solution, 2 grams per vial of methylprednisolone sodium succinate for intramuscular or intravenous use. The single-dose vial requires reconstitution with 30 mL Bacteriostatic Water for Injection containing benzyl alcohol preservative. Distributed by Pharmacia & Upjohn Company LLC, a division of Pfizer Inc.*

FDA Label Image

Principal Display Panel (2 grams Vial Carton)

Solu-Medrol 2 grams per vial injection powder for solution, labeled for intramuscular or intravenous use only. The packaging highlights methylprednisolone sodium succinate as the active ingredient and notes the vial is single-dose with no diluent included. Distributed by Pharmacia & Upjohn Company LLC, the label specifies recommended diluent as bacteriostatic water for injection containing benzyl alcohol as a preservative.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.